Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study

Aditi Shendre1, Howard W Wiener1, Marguerite R Irvin1

  • 1Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

Plos One
|December 6, 2017
PubMed

Insights

This study explored genetic links to cardiovascular disease risk in Black women with and without HIV. Findings suggest European ancestry influences common carotid artery intima-media thickness, a marker for atherosclerosis.

Area of Science:

  • Genetics and Genomics
  • Cardiovascular Health
  • HIV Research

Background:

  • Cardiovascular disease (CVD) is a significant comorbidity in individuals with HIV.
  • Common carotid artery intima-media thickness (cCIMT) is a validated marker for subclinical atherosclerosis and CVD risk.
  • Understanding genetic factors contributing to CVD in HIV-infected populations is crucial.

Purpose of the Study:

  • To investigate genome-wide associations (GWA) and admixture patterns related to cCIMT in Black women.
  • To analyze these associations separately in HIV-positive and HIV-negative women.
  • To identify genetic variants and ancestry-related regions associated with atherosclerosis markers.

Main Methods:

  • Genome-wide association (GWA) and admixture analysis were performed on 682 HIV-positive and 288 HIV-negative Black, non-Hispanic women from the Women's Interagency HIV Study (WIHS).
  • Combined and stratified analyses were used to assess genetic associations.
  • Top single nucleotide polymorphisms (SNPs) and significant local ancestry regions were identified.

Main Results:

  • No SNPs reached genome-wide statistical significance, but suggestive associations were found.
  • Top GWAS SNPs included rs2280828 (MED30 | EXT1), rs2907092 (CTNND2), and rs7529733 (FAM5C | RGS18).
  • Significant local European ancestry associations were identified on chromosomes 19 and 10, implicating genes like ZSCAN5D, NDUF1, VN1R6P, ZNF845, SEC23IP, and PPAPDC1A.

Conclusions:

  • Local European ancestry appears to play a role in the genetic associations of cCIMT in Black women within the WIHS cohort.
  • Findings suggest a complex interplay between genetic factors, local ancestry, and environmental influences on CVD risk in this population.
  • Identified SNPs and gene regions warrant further investigation and validation in independent cohorts.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.8K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
586
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460